Bellerophon Therapeutics所有资讯

Bellerophon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(0.0%),Joseph Edelman(0.0%)等

02/15 05:55

Bellerophon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(0.0%),Tang Capital Management, LLC(0.0%)等

02/15 05:03

Bellerophon Therapeutics | SC 13G：超过5%持股股东披露文件-507 Summit LLC(8.4%),Lepercq Capital Management LLC(8.4%)等

01/26 23:49

Bellerophon Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Theodore Wang(0.5%),Puissance Life Science Opportunities Fund VI(0%)等

2023/10/18 09:05

Bellerophon Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Theodore Wang(0.5%),Puissance Life Science Opportunities Fund VI(0%)等

2023/10/17 08:56

Bellerophon Therapeutics | 4：持股变动声明-股东 Puissance Capital Management LP

2023/10/17 08:51

Bellerophon Therapeutics | 4：持股变动声明-董事 Amin Naseem

2023/06/10 04:12

Bellerophon Therapeutics | 4：持股变动声明-高管 Fernandes Peter

2023/06/10 04:12

Bellerophon Therapeutics | 4：持股变动声明-高管 Shah Parag Suresh

2023/06/10 04:11

Bellerophon Therapeutics | 4：持股变动声明-高管 Dekker Martin

2023/06/10 04:11

Bellerophon Therapeutics | 4：持股变动声明-董事 Bruder Scott P

2023/06/10 04:11

Bellerophon Therapeutics | 4：持股变动声明-高管 Kim Bobae

2023/06/10 04:10

Bellerophon Therapeutics | 4：持股变动声明-董事 Wang Theodore T

2023/06/10 04:10

Bellerophon Therapeutics | 4：持股变动声明-董事 Cloyd Mary Ann

2023/06/10 04:10

Bellerophon Therapeutics | 4：持股变动声明-董事 Teufel Crispin

2023/06/10 04:10

Bellerophon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Janus Henderson Group plc(0%),Janus Henderson Biotech Innovation Master Fund Ltd(0%)

2023/06/10 01:03

Bellerophon Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Theodore Wang(10.9%),Puissance Life Science Opportunities Fund VI(10.3%)等

2023/06/08 09:44

Bellerophon Therapeutics | 4：持股变动声明-股东 Puissance Life Science Opportunities Fund VI

2023/06/08 09:21

Bellerophon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Janus Henderson Group plc(12.1%),Janus Henderson Biotech Innovation Master Fund Ltd(10.4%)

2023/05/27 04:41

Bellerophon Therapeutics | SC 13G：超过5%持股股东披露文件-Janus Henderson Group plc(5.1%),Janus Henderson Biotech Innovation Master Fund Ltd(5.1%)

2023/05/25 23:17